The chairman of Appollon Jamaica is upbeat at the prospects of a formula being able to kill breast cancer cells after test results show positive signs.
In a PRNewswire release, Paul Burke, Chairman and CEO of Apollon Jamaica commented that, “test results and the plan to begin treatments in Jamaica are very exciting developments. Traditional chemotherapy, radiation and surgery cancer treatment protocols are expensive and require a great deal of infrastructure. As a result many women in Jamaica and worldwide have gone without, or with only limited, treatment.” The Apollon Jamaica Chairman went on to say, “The combined formulations of Apollon and Aion are expected to be comparatively inexpensive, providing an opportunity for all women to have their breast cancer treated. I look forward to collaborating with Aion with regard to our shared vision to bring these formulations to market as quickly as possible and in a manner that allows all Jamaican women with HER2+ breast cancer, as well as, women traveling from international locations to Jamaica as medical tourists for our treatment, to have access to quality care.”
for further information check out https://www.prnewswire.com/news-releases/combined-apollon-and-aion-formulations-kill-breast-cancer-cells-through-multiple-pathways-301294012.html